Product
Adjuvant treatment
1 clinical trial
2 indications
Indication
Neuroendocrine CarcinomaIndication
Cancer of the Digestive SystemClinical trial
Phase II Study to Evaluate the Efficacy of 12-month Neoadjuvant Chemotherapy in Terms of Disease-free Survival in Patients With Localized Digestive Neuroendocrine CarcinomasStatus: Recruiting, Estimated PCD: 2034-01-01